{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T14:34:15Z","timestamp":1779114855665,"version":"3.51.4"},"reference-count":19,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["amjmed.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Medicine"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.amjmed.2023.01.027","type":"journal-article","created":{"date-parts":[[2023,2,5]],"date-time":"2023-02-05T01:15:21Z","timestamp":1675559721000},"page":"504-506","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Naloxone Over the Counter: Increasing Opportunities and Challenges for Health Providers"],"prefix":"10.1016","volume":"136","author":[{"given":"Amalia D.","family":"Ardeljan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin","family":"Fiedler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lawrence","family":"Fiedler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George R.","family":"Luck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dennis G.","family":"Maki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa","family":"Clayton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles H.","family":"Hennekens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3815-3358","authenticated-orcid":false,"given":"Allison","family":"Ferris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjmed.2023.01.027_bib0001","unstructured":"US Food and Drug Administration (FDA). FDA announces preliminary assessment that certain naloxone products have the potential to be safe and effective for over-the-counter use: agency continues to encourage sponsor applications for their over-the counter naloxone products. Available at:https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-announces-preliminary-assessment-certain-naloxone-products-have-potential-be-safe-and-effective. Accessed December 31, 2022."},{"key":"10.1016\/j.amjmed.2023.01.027_bib0002","unstructured":"Cision PR Newswire. Harm reduction therapeutics' new drug application for RiVive\u2122 over-the-counter naloxone nasal spray accepted and granted priority review by FDA. Available at:https:\/\/www.prnewswire.com\/news-releases\/harm-reduction-therapeutics-new-drug-application-for-rivive-over-the-counter-naloxone-nasal-spray-accepted-and-granted-priority-review-by-fda-301710002.html. Accessed December 31, 2022."},{"key":"10.1016\/j.amjmed.2023.01.027_bib0003","unstructured":"Jordan MR, Morrisonponce D. Naloxone. Treasure Island, FL: Stat Pearls Publishing; 2022. Available at: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK441910. Accessed December 31, 2022."},{"issue":"1","key":"10.1016\/j.amjmed.2023.01.027_bib0004","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.annemergmed.2019.04.006","article-title":"Pulmonary complications of opioid overdose treated with naloxone","volume":"75","author":"Farkas","year":"2019","journal-title":"Ann Emerg Med"},{"issue":"1","key":"10.1016\/j.amjmed.2023.01.027_bib0005","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s12916-018-1058-y","article-title":"Healthcare costs and utilization associated with high-risk prescription opioid use: a retrospective cohort study","volume":"16","author":"Chang","year":"2018","journal-title":"BMC Med"},{"key":"10.1016\/j.amjmed.2023.01.027_bib0006","unstructured":"Centers for Disease Control, National Center for Health Statistics. Drug Overdose Deaths in the U.S. Top 100,000 Annually. Available at: https:\/\/www.cdc.gov\/mmwr\/volumes\/71\/wr\/mm7150a2.htm?s_cid=mm7150a2_2022. Accessed December 31, 2022."},{"key":"10.1016\/j.amjmed.2023.01.027_bib0007","unstructured":"United States Department of Justice; Drug Enforcement Administration. Drug fact sheet. Fentanyl. October 2022. Available at: https:\/\/www.dea.gov\/factsheets\/fentanyl. Accessed December 31, 2022."},{"key":"10.1016\/j.amjmed.2023.01.027_bib0008","unstructured":"United States Drug Enforcement Administration. Public Safety Alert. DEA laboratory testing reveals that 6 out of 10 fentanyl-lacked fake prescription pills now contain a potentially lethal dose of fentanyl. Available at:https:\/\/www.dea.gov\/alert\/dea-laboratory-testing-reveals-6-out-10-fentanyl-laced-fake-prescription-pills-now-contain Accessed December 31, 2022."},{"key":"10.1016\/j.amjmed.2023.01.027_bib0009","unstructured":"GoodRx. Generic Narcan naloxone. Available at: https:\/\/www.goodrx.com\/narcan. Accessed December 31, 2022."},{"key":"10.1016\/j.amjmed.2023.01.027_bib0010","unstructured":"GoodRx. Generic EpiPen epinephrine. Available at: https:\/\/www.goodrx.com\/epipen. Accessed December 31, 2022."},{"key":"10.1016\/j.amjmed.2023.01.027_bib0011","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jsat.2016.08.006","article-title":"Opioid overdose experience, risk behaviors, and knowledge in drug users from a rural versus an urban setting","volume":"71","author":"Dunn","year":"2016","journal-title":"J Subst Abuse Treat"},{"key":"10.1016\/j.amjmed.2023.01.027_bib0012","unstructured":"Centers for Disease Control and Prevention (CDC). Opioid dispensing rate maps. Available at: https:\/\/www.cdc.gov\/drugoverdose\/rxrate-maps\/index.html. Accessed December 31, 2022."},{"key":"10.1016\/j.amjmed.2023.01.027_bib0013","unstructured":"Bella T. West Point cadets overdose on fentanyl while on spring break in South Florida, police say. Washington Post March 12, 2022. Available at:https:\/\/www.washingtonpost.com\/nation\/2022\/03\/12\/west-point-cadets-overdose-fentanyl\/. Accessed December 31, 2022."},{"key":"10.1016\/j.amjmed.2023.01.027_bib0014","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2021.108772","article-title":"Predictors of US states\u2019 adoption of naloxone access laws, 2001-2017","volume":"225","author":"Bohler","year":"2021","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.amjmed.2023.01.027_bib0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2020.100581","article-title":"The menacing assaults on science, FDA, CDC, and health of the US public","volume":"27","author":"Alter","year":"2020","journal-title":"EClinicalMedicine"},{"issue":"4","key":"10.1016\/j.amjmed.2023.01.027_bib0016","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.amjmed.2012.07.007","article-title":"Mortality from homicide among young Black men: a new American tragedy","volume":"126","author":"Hennekens","year":"2013","journal-title":"Am J Med"},{"issue":"8","key":"10.1016\/j.amjmed.2023.01.027_bib0017","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.amjmed.2019.02.012","article-title":"Alarming trends in mortality from firearms among United States schoolchildren","volume":"132","author":"Rubenstein","year":"2019","journal-title":"Am J Med"},{"issue":"3","key":"10.1016\/j.amjmed.2023.01.027_bib0018","doi-asserted-by":"crossref","first-page":"e210","DOI":"10.1016\/S2468-2667(21)00304-2","article-title":"Estimating naloxone need in the USA across fentanyl, heroin, and prescription opioid epidemics: a modelling study","volume":"7","author":"Irvine","year":"2022","journal-title":"Lancet Public Health"},{"key":"10.1016\/j.amjmed.2023.01.027_bib0019","unstructured":"Wikipedia. Quote from plaque on Richard Doll Building. Available at:https:\/\/en.wikipedia.org\/wiki\/Richard_Doll_Building. Accessed December 31, 2022."}],"container-title":["The American Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934323000694?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934323000694?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T09:30:16Z","timestamp":1757583016000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002934323000694"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":19,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["S0002934323000694"],"URL":"https:\/\/doi.org\/10.1016\/j.amjmed.2023.01.027","relation":{},"ISSN":["0002-9343"],"issn-type":[{"value":"0002-9343","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Naloxone Over the Counter: Increasing Opportunities and Challenges for Health Providers","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjmed.2023.01.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}